TM

Technomark Medical Ventures

Europe, England, United Kingdom, London

Description

TMV is a venture capital arm of Technomark Consulting Services Limited.

Investor Profile

Technomark Medical Ventures has made 3 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series C (33%)
  • Series A (33%)
  • Series B (33%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Technomark Medical Ventures frequently co-invest with?

ABN AMRO Fund
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Scottish Equity Partners
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
WD
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 3
Avalon Ventures
North America, California, United States, La Jolla
Co-Investments: 1
Excalibur Fund Managers
Europe, England, United Kingdom, London
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
PV
Europe, England, United Kingdom, London
Co-Investments: 1
CLSA
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
GeneChem
Asia, Taejon-jikhalsi, South Korea, Daejeon
Co-Investments: 1
LDC
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Technomark Medical Ventures?

BioVex

Oxton, York, United Kingdom

BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.

BiotechnologyHealth CareMedical
Series COct 6, 2003
Amount Raised: $28,382,767
BioVex

Oxton, York, United Kingdom

BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.

BiotechnologyHealth CareMedical
Series BJul 30, 2001
Amount Raised: $14,263,056
BioVex

Oxton, York, United Kingdom

BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.

BiotechnologyHealth CareMedical
Series AFeb 1, 1999
Amount Raised: $4,925,170